Assessment according to §137h SGB V
Implantation via injection under endoscopic ultrasound guidance of 32P-labeled microparticles for unresectable, locally advanced pancreatic tumours
Report documents
-
Extract of the assessment according to §137h SGB V
Implantation via injection under endoscopic ultrasound guidance of 32P-labeled microparticles for unresectable, locally advanced pancreatic tumours
-
Assessment according to §137h SGB V
Implantation via injection under endoscopic ultrasound guidance of 32P-labeled microparticles for unresectable, locally advanced pancreatic tumours
Press releases
High-risk medical devices: No comparative data available for two new methods
IQWiG assessed one new invasive procedure each for the treatment of pancreatic tumours and uterine fibroids. Due to a lack of robust data, the Institute outlined testing studies for both methods.
Project details
- Project no.
- H21-13
- Commission
- Commission awarded on 13.12.2021 by the Federal Joint Committee (GBA).
- Report type
- Assessment according to §137h SGB V
- Status
- Commission completed
- Department/Division
- Non-Drug Interventions
- Topic
- Cancer
- Note
-
As part of the procedures according to §137h SGB V (German version), the Federal Joint Committee (GBA) commissioned IQWiG to assess this examination or treatment method.
Connected Projects
-
Assessment according to §137h SGB V
Implantation via injection under endoscopic ultrasound guidance of 32P-labeled microparticles for unresectable, locally advanced pancreatic tumours - Addendum to commission H21-13
Status: Commission completed